An update on assessment and treatment of complex attention-deficit hyperactivity disorder.
Hunt
R D
RD
Department of Psychiatry, Vanderbilt University, USA.
Paguin
A
A
Payton
K
K
D000293:Adolescent; D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use*; D000927:Anticonvulsants / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001289:Attention Deficit Disorder with Hyperactivity / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D002648:Child; D004359:Drug Therapy, Combination; D006801:Humans
D000316:Adrenergic alpha-Agonists; D000927:Anticonvulsants; D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D000697:Central Nervous System Stimulants